Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
AZD9793 for Liver Cancer
Recruiting1 awardPhase 1 & 2
Saint Louis, Missouri
This trial is testing if a new treatment called AZD9793 is safe and effective in patients with advanced solid tumors that have a specific marker called GPC3.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service